Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Covid-19 tests emergency authorized by FDA 20th March 2020, by price move

As of March 20, 2020, nine companies have had Covid-19 diagnostic tests authorized by the U.S. FDA. This statistic shows the FDA emergency use authorisations for Covid-19 tests (excluding academic-developed tests) as of 20 March, 2020, by 1-day share price move. After GenMark Diagnostics got an emergency use authorization (EUA) on March 19, its share price increased 41 percent over one day.

FDA emergency use authorizations for Covid-19 tests as of 20 March, 2020, by company 1-day share price move*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

March 2020

Region

United States

Survey time period

as of March 20, 2020

Supplementary notes

* Excludes academic-developed tests.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus (COVID-19) in India"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.